Are negotiators ‘fighting to lower drug prices’ actually making them higher? – By Ryan King (Washington Examiner) / February 07, 2022
As many people express concern over high drug prices, an increasing number of companies have emerged claiming to be their champions against Big Pharma.
Yet pharmacy benefit managers, also known as PBMs, who are tasked with negotiating drug prices with drug manufacturers, have faced bipartisan accusations that they are the ones who contribute to increased list prices for important drugs. PBMs have pushed back against these accusations.
“There’s a lot of finger-pointing going on, but there’s plenty of blame to go around,” Robin Feldman, professor at UC Hastings College of Law, told the Washington Examiner. “Really, everyone is feeding at the trough, and consumers and taxpayers are paying the bill on all of these things.”
